- ten Berg JM, Kelder JC, Suttorp MJ, Plokker THW. Provisional stenting in the real world: results in 1058 consecutive patients undergoing percutaneous coronary angioplasty. lnt J Cardiovasc Intervent 2001; 18(4): 731-733.
- The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
- The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-1696.
- The IMPACT II Investigators. Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet 1997; 349: 1422-1428.
- The EPISTENT Investigators. Randomized placebocontrolled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoproteinIIb/IIIa blockade. Lancet 1998; 352: 87-92.
- Serruys PW, linger F, Sousa JE et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124.
- Corcos T, Favereau X, Guèrin Y, Narins CR, Topol J, Holmes DR Jr. A call for professional stenting: the balloon is dead and buried! Response. Circulation 1998; 98: 2644-2645.
- Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495.
- Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501
- Erbel R, Haude M, Hopp HW et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis stent study group. N Engl J Med 1998; 339: 1672-1678.
- Sirnes PA, GoIf S, Myreng Y et al. Related Articles, Books, Linkout stenting in chronic coronary occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444-1451.
- Kleiman NS, Califf RM, Koning RA. Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. J Am Coll Cardiol 2000; 36: 310-325.
- Transcatheter Cardiovascular Therapeutics 2000: late-breaking clinical trials, E Garcia, RAP. Available at http://www.tctmd.com/clinical-trials/breaking/onehtml?presentation_id=22.
- Savage MP, Douglas JS Jr, Fischman DL et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997; 337: 740-747.
- Kobayashi Y, De Gregorio J, Kobayashi N et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999; 34: 651-659.
- Transcatheter Cardiovascular Therapeutics 2000: late-breaking clinical trials, PW Serruys, ADVANCE. Available at http://www.tctmd.com/clinical-trials/breaking/onehtml?presentation_id=21.
- Colombo A, De Gregorio J, Moussa I et al. Intravascular ultrasound guided-PTCA with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol 2001; 38(5): 1427-1433.
- Topol E, Mark DB, Lincoff AM et al. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. Lancet 1999; 354: 2019-2024.
- Hamm CW, Heeschen C, Gorldman B et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999; 340: 1623-1629.
International Journal of Cardiovascular Interventions
Volume 4, 2001 - Issue 3